Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The person must be female.
- People who have an ovarian or adnexal (near the ovary) mass and are scheduled to have surgery or a biopsy/tissue sample taken for the first time at the participating centre for this current growth, with a confirmed tissue diagnosis expected to be available.
- Scans done during the screening process show a cyst, mixed cyst-solid, or solid mass on one or both ovaries that needs further investigation to determine what it is.
- A blood sample can be collected before the first surgery or before any cancer-related treatment begins for the current mass, and that sample can be processed and stored correctly within the required timeframe.
- Medical records and tissue results after the procedure are expected to be complete enough to provide the key information needed for the study's analysis.
- The person, or their legally authorised representative, has voluntarily given written consent to participate after being fully informed about the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have already received cancer treatments such as chemotherapy, targeted therapy, immunotherapy, or radiotherapy for the current mass, or who have already had the tumour fully removed or had comprehensive staging surgery and are now having surgery only for a remaining or returned growth.
- People for whom no tissue diagnosis is ultimately obtained, or where no clear conclusion from the tissue sample can be established.
- People whose scans at screening strongly suggest a common non-cancerous cyst type called a benign mature cystic teratoma.
- People who have ovarian cancer alongside another separate cancer diagnosis.
- People where there were clear problems during blood sample collection, transport, or handling — such as the sample being severely broken down, contaminated, or too small — meaning the sample does not meet the quality requirements needed for the planned testing.
- People who have any other condition that, in the investigator's judgement, makes participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-27-83662681
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic sensitivity; Diagnostic specificity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.